Analysts Expect Harvard Bioscience, Inc. (HBIO) to Announce $0.05 EPS

January 13, 2018
Harvard Bioscience, Inc. (NASDAQ:HBIO) has been given a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating. Brokers have set a twelve-month consensus price objective of $5.50 for the company and […]
Read more at:https://www.americanbankingnews.com/2018/01/13/analysts-expect-harvard-bioscience-inc-hbio-to-announce-0-05-eps.html

Site Created by finaceandbankingnewsnow.com